Literature DB >> 23740002

The use of allelic imbalance to ascertain cis-regulation for human UGT2B7 in vivo.

Pin-Yi Wang, Dezheng Huo, Chang Sun, Olufunmilayo I Olopade.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23740002      PMCID： PMC3748163          DOI： 10.1007/s00228-013-1538-0

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN： 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  23 in total

Review 1.  Human UDP-glucuronosyltransferases: metabolism, expression, and disease.

Authors:  R H Tukey; C P Strassburg
Journal:  Annu Rev Pharmacol Toxicol       Date:  2000       Impact factor: 13.820

2.  Allelic imbalance (AI) identifies novel tissue-specific cis-regulatory variation for human UGT2B15.

Authors:  Chang Sun; Catherine Southard; David B Witonsky; Olufunmilayo I Olopade; Anna Di Rienzo
Journal:  Hum Mutat       Date:  2010-01       Impact factor: 4.878

3.  Relative enzymatic activity, protein stability, and tissue distribution of human steroid-metabolizing UGT2B subfamily members.

Authors:  D Turgeon; J S Carrier; E Lévesque; D W Hum; A Bélanger
Journal:  Endocrinology       Date:  2001-02       Impact factor: 4.736

Review 4.  UDP-glucuronosyltransferases.

Authors:  C D King; G R Rios; M D Green; T R Tephly
Journal:  Curr Drug Metab       Date:  2000-09       Impact factor: 3.731

5.  SNP discovery, expression and cis-regulatory variation in the UGT2B genes.

Authors:  C Sun; C Southard; D Huo; R D Hernandez; D B Witonsky; O I Olopade; A Di Rienzo
Journal:  Pharmacogenomics J       Date:  2011-03-01       Impact factor: 3.550

6.  Single nucleotide polymorphism discovery and functional assessment of variation in the UDP-glucuronosyltransferase 2B7 gene.

Authors:  Federico Innocenti; Wanqing Liu; Donna Fackenthal; Jacqueline Ramírez; Peixian Chen; Xin Ye; Xiaolin Wu; Wei Zhang; Snezana Mirkov; Soma Das; Edwin Cook; Mark J Ratain
Journal:  Pharmacogenet Genomics       Date:  2008-08       Impact factor: 2.089

7.  Expression of UGT1A and UGT2B mRNA in human normal tissues and various cell lines.

Authors:  Akiko Nakamura; Miki Nakajima; Hiroyuki Yamanaka; Ryoichi Fujiwara; Tsuyoshi Yokoi
Journal:  Drug Metab Dispos       Date:  2008-05-14       Impact factor: 3.922

8.  Quantitative analysis of UDP-glucuronosyltransferase (UGT) 1A and UGT2B expression levels in human livers.

Authors:  Takeshi Izukawa; Miki Nakajima; Ryoichi Fujiwara; Hiroyuki Yamanaka; Tatsuki Fukami; Masataka Takamiya; Yasuhiro Aoki; Shin-ichi Ikushiro; Toshiyuki Sakaki; Tsuyoshi Yokoi
Journal:  Drug Metab Dispos       Date:  2009-05-13       Impact factor: 3.922

9.  Determination of mRNA expression of human UDP-glucuronosyltransferases and application for localization in various human tissues by real-time reverse transcriptase-polymerase chain reaction.

Authors:  Shuji Ohno; Shizuo Nakajin
Journal:  Drug Metab Dispos       Date:  2008-10-06       Impact factor: 3.922

10.  Pharmacokinetic and pharmacodynamic interaction of lorazepam and valproic acid in relation to UGT2B7 genetic polymorphism in healthy subjects.

Authors:  J-Y Chung; J-Y Cho; K-S Yu; J-R Kim; K S Lim; D-R Sohn; S-G Shin; I-J Jang
Journal:  Clin Pharmacol Ther       Date:  2007-08-08       Impact factor: 6.875
View more
  1 in total

1.  Identification of rs11615992 as a novel regulatory SNP for human P2RX7 by allele-specific expression.

Authors:  Tao Peng; Li Zhong; Jing Gao; Zhu Wan; Wei-Ping Fu; Chang Sun
Journal:  Mol Genet Genomics       Date:  2019-08-13       Impact factor: 3.291
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.